Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing, China.
Department of Nephrology, Peking University First Hospital, Beijing, China.
PLoS One. 2020 Dec 2;15(12):e0243195. doi: 10.1371/journal.pone.0243195. eCollection 2020.
The current worldwide pandemic of Coronavirus Disease 2019 (COVID-19) has posed a serious threat to global public health, and the mortality rate of critical ill patients remains high. The purpose of this study was to identify factors that early predict the progression of COVID-19 from severe to critical illness.
This retrospective cohort study included adult patients with severe or critical ill COVID-19 who were consecutively admitted to the Zhongfaxincheng campus of Tongji Hospital (Wuhan, China) from February 8 to 18, 2020. Baseline variables, data at hospital admission and during hospital stay, as well as clinical outcomes were collected from electronic medical records system. The primary endpoint was the development of critical illness. A multivariable logistic regression model was used to identify independent factors that were associated with the progression from severe to critical illness.
A total of 138 patients were included in the analysis; of them 119 were diagnosed as severe cases and 16 as critical ill cases at hospital admission. During hospital stay, 19 more severe cases progressed to critical illness. For all enrolled patients, longer duration from diagnosis to admission (odds ratio [OR] 1.108, 95% CI 1.022-1.202; P = 0.013), pulse oxygen saturation at admission <93% (OR 5.775, 95% CI 1.257-26.535; P = 0.024), higher neutrophil count (OR 1.495, 95% CI 1.177-1.899; P = 0.001) and higher creatine kinase-MB level at admission (OR 2.449, 95% CI 1.089-5.511; P = 0.030) were associated with a higher risk, whereas higher lymphocyte count at admission (OR 0.149, 95% CI 0.026-0.852; P = 0.032) was associated with a lower risk of critical illness development. For the subgroup of severe cases at hospital admission, the above factors except creatine kinase-MB level were also found to have similar correlation with critical illness development.
Higher neutrophil count and lower lymphocyte count at admission were early independent predictors of progression to critical illness in severe COVID-19 patients.
当前,2019 年冠状病毒病(COVID-19)在全球范围内的大流行对全球公共卫生构成了严重威胁,重症患者的死亡率仍然很高。本研究旨在确定能够早期预测 COVID-19 由重症向危重症发展的因素。
本回顾性队列研究纳入了 2020 年 2 月 8 日至 18 日连续入住华中科技大学同济医院中法新城院区的成人重症或危重症 COVID-19 患者。从电子病历系统中收集基线变量、入院时和住院期间的数据以及临床结局。主要终点是发展为危重症。使用多变量逻辑回归模型确定与从重症向危重症进展相关的独立因素。
共纳入 138 例患者;其中,入院时 119 例诊断为重症,16 例诊断为危重症。住院期间,又有 19 例重症患者进展为危重症。对于所有入组患者,从确诊到入院的时间较长(比值比 [OR] 1.108,95%置信区间 [CI] 1.022-1.202;P=0.013)、入院时脉搏血氧饱和度<93%(OR 5.775,95% CI 1.257-26.535;P=0.024)、较高的中性粒细胞计数(OR 1.495,95% CI 1.177-1.899;P=0.001)和较高的肌酸激酶同工酶-MB 水平(OR 2.449,95% CI 1.089-5.511;P=0.030)与更高的危重症风险相关,而入院时较高的淋巴细胞计数(OR 0.149,95% CI 0.026-0.852;P=0.032)与较低的危重症发展风险相关。对于入院时为重症的亚组患者,除肌酸激酶同工酶-MB 水平外,上述因素也与危重症的发展具有类似的相关性。
入院时较高的中性粒细胞计数和较低的淋巴细胞计数是重症 COVID-19 患者向危重症发展的早期独立预测因素。